Consultant, Medical Oncologist

Dr. Kritika Mehrotra

Dr. Kritika Mehrotra is a dynamic medical oncologist with a comprehensive understanding of solid tumors and systemic cancer care, developed through diverse exposure across medical, radiation, and hemato-oncology. Her clinical journey spans both high-volume academic centers and advanced corporate hospitals, giving her an early edge in managing complex cancer cases with precision and empathy.

Her clinical interests lie in the multidisciplinary management of solid cancers. She is especially passionate about bridging the gap between diagnosis and timely intervention, with a strong emphasis on preventive oncology, patient education, and treatment adherence.

She is actively engaged in academic research and is committed towards contributing to evidence-based oncology practices through teaching, mentorship, and multidisciplinary forums.

Dr. Mehrotra is known for her empathetic approach, patient-first mindset, and a strong commitment to advancing accessible and timely cancer care in both urban and underserved settings.

MBBS & Internship: Himalayan Institute of Medical Sciences, Dehradun

MD (Radiation Oncology): MJP Rohilkhand University (Gold Medalist, University Topper)

DM (Medical Oncology): Jawaharlal Nehru Medical College, Belagavi

Consultant, Medical Oncology
SunAct Cancer Institute, Mumbai | Jun 2025 – Present

Senior Resident – Medical Oncology
Jawaharlal Nehru Medical College, Belagavi | Apr 2022 – Apr 2025

Senior Resident – Radiation Oncology
Fortis Memorial Research Institute, Gurgaon | Apr 2021 – Oct 2021

Senior Resident – Radiation Oncology
Sri Ram Murti Smarak Institute of Medical Sciences, Bareilly | Aug 2020 – Oct 2020

Junior Resident – MD Radiation Oncology
SRMSIMS, Bareilly | Jun 2017 – Aug 2020

Junior Resident (Non-Academic)
AIIMS, Rishikesh | Mar 2015 – Sep 2015

MBBS & Internship
Himalayan Institute of Medical Sciences, Dehradun | Aug 2008 – Feb 2014

PROFESSIONAL MEMBERSHIPS

  • AMC
  • ICON
  • ISMPO
  • Mumbai Hematology Group
  • AROI
  • ASTRO
  • ASCO
  • ESMO
  • IAPC


CONFERENCES & ACADEMIC ACTIVITIES

  • Multiple national & state-level oncology conferences, 2018-2025
  • Tutor – SRMS Contouring Workshops, 2019, 2020
  • Reviewer in IJMPO
  • Faculty & Panelist, Best of ASCO, 2025 
  • Poster presentation, ICC Mumbai, 2023 
  • Poster presentation, GI-CON2022 
  • Oral paper presentation, AROICON, 2020
  • Poster presentation, UPAROICON, 2018
  • Certification course, Indian Association of Palliative Care
  • Faculty Best of ASCO, 2025
  • Best poster GI CON, 2023
  • Best Abstract ICC, 2023, Mumbai
  • Gold Medal MD, 2020
  • Best Oral Paper UPAROICON
  • AROI Travel Fellowship
  • Survival Analysis of Non-Metastatic Triple Negative Breast Cancer in a Tertiary Care Centre in North Karnataka – Asia Pacific Journal of Cancer Care, June 2025
  • 3D Conformal versus IMRT in head and neck squamous cell carcinoma: Comparative analysis of compliance, toxicities and dosimetric parameters– SRMS Journal

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct head and neck cancer case study using TCR-p53 therapy in inoperable squamous cell carcinoma
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male